Skip to main content
Premium Trial:

Request an Annual Quote

The State of Sequencing

Art Wuster at Seqonomics ponders the state of sequencing in Japan. "Considering that Japan is one of the world's most important scientific nations, its DNA sequencing capacity is surprisingly low," Wuster writes. "There are more sequencing machines in the Netherlands or in Spain, both of which spend only a fraction of what Japan does on research and development." He suggests that a recent "lack of growth in the biotechnology and medical sectors, combined with a scarcity of public funding for genomics," are to blame for this.

But the outlook is not all bleak, he adds, as Japan's "Hokkaido System Science, a company that provides DNA synthesis and sequencing services, is flourishing and aims to expand internationally. And then there is of course Riken, Japan's flagship natural sciences research institute, whose impressive infrastructure includes ten next generation sequencers."

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.